Fennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Senior Officer Robert Christopher Andrade bought 8,220 shares of the stock in a transaction on Monday, June 2nd. The shares were purchased at an average price of C$6.99 per share, with a total value of C$57,433.14.
Fennec Pharmaceuticals Stock Up 1.5%
Shares of TSE FRX traded up C$0.17 during mid-day trading on Thursday, hitting C$11.33. The company had a trading volume of 136 shares, compared to its average volume of 1,205. The company has a market capitalization of C$218.50 million, a PE ratio of -191.93 and a beta of 0.25. The firm has a 50-day simple moving average of C$8.72 and a two-hundred day simple moving average of C$8.86. The company has a current ratio of 7.80, a quick ratio of 10.17 and a debt-to-equity ratio of -620.83. Fennec Pharmaceuticals Inc. has a one year low of C$5.65 and a one year high of C$11.68.
About Fennec Pharmaceuticals
(
Get Free Report)
Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.
Featured Stories
Before you consider Fennec Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fennec Pharmaceuticals wasn't on the list.
While Fennec Pharmaceuticals currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
